바이오테크놀러지 공급망 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global biotech supply chain market size is expected to reach USD 50.18 Billion in 2034 from USD 25.74 Billion in 2025, growing at a CAGR of 7.7% during 2026-2034.This market is growing as biotechnology companies expand manufacturing capabilities and respond to increasing demand for vaccines, biologics, cell and gene therapies, and advanced therapeutics. Biotech supply chains require specialized logistics, temperature-controlled transportation, raw materials, specialized equipment, and regulatory compliance. The complexity of these requirements is encouraging companies to adopt more sophisticated supply chain management strategies. Increasing outsourcing of manufacturing and logistics activities is also contributing to market expansion. As biotechnology pipelines become more diversified, companies are placing greater emphasis on supply chain visibility, resilience, and operational efficiency.

One of the key growth drivers is the increasing complexity of biologics and personalized medicines, which often require highly controlled storage and transportation conditions. Supply chain disruptions have also encouraged biotechnology companies to diversify suppliers, maintain strategic inventories, and strengthen real-time monitoring capabilities. Digital technologies such as cloud platforms, artificial intelligence, Internet of Things sensors, and predictive analytics are helping organizations improve demand forecasting and shipment visibility. Regulatory requirements surrounding product traceability and quality assurance further support investment in specialized supply chain solutions and services across the biotechnology ecosystem.

Future prospects are promising as biotechnology production becomes more globalized and personalized therapies gain wider acceptance. Companies are expected to invest increasingly in automated inventory management, predictive analytics, blockchain-enabled traceability, and intelligent logistics platforms. Cold-chain infrastructure is likely to remain a major area of investment because many biological products require precise temperature control. Emerging markets are also expected to create new opportunities as pharmaceutical and biotechnology manufacturing expands. Greater collaboration among manufacturers, logistics providers, technology companies, and regulators will further strengthen supply chain resilience and support long-term market development.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Offering

• Software/Platforms
• Hardware
• Services

By Product Type

• Cell & Gene Therapies
• Plasma-Derived Products
• Biosimilars & Biologics
• Vaccines
• Others

By Supply Chain Stage

• Procurement & Supplier Management
• Manufacturing Supply Coordination
• Packaging & Labeling
• Warehousing & Inventory Management
• Transportation & Distribution
• Others

By Application

• Clinical Trial Supply Chain Management
• Commercial Biologics Distribution
• Cold Chain & Temperature-Controlled Logistics
• API, Raw Material & Consumables Supply Management
• Serialization, Traceability & Compliance
• Others

By End User

• Pharmaceutical Companies & Biotechnology Companies
• CDMOs & CROs
• Academic & Research Institutes
• Others

COMPANIES PROFILED

• Deutsche Post AG, United Parcel Service of America Inc., Cencora Inc., FedEx Healthcare Solutions, Kuehne+Nagel, McKesson Corporation, Cardinal Health, Thermo Fisher Scientific Inc., Catalent Inc., A.P. Moller - Maersk, DB Schenker, CEVA Logistics, DSV A/S, GXO Logistics, SF Express, Cryoport Inc., Marken, World Courier, DHL Global Forwarding, Lineage Logistics

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOTECH SUPPLY CHAIN MARKET: BY OFFERING 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Offering
• 4.2. Software/Platforms Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Hardware Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOTECH SUPPLY CHAIN MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Product Type
• 5.2. Cell & Gene Therapies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Plasma-Derived Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Biosimilars & Biologics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Vaccines Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOTECH SUPPLY CHAIN MARKET: BY SUPPLY CHAIN STAGE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Supply Chain Stage
• 6.2. Procurement & Supplier Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Manufacturing Supply Coordination Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Packaging & Labeling Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Warehousing & Inventory Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Transportation & Distribution Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIOTECH SUPPLY CHAIN MARKET: BY APPLICATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Application
• 7.2. Clinical Trial Supply Chain Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Commercial Biologics Distribution Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Cold Chain & Temperature-Controlled Logistics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. API, Raw Material & Consumables Supply Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Serialization, Traceability & Compliance Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL BIOTECH SUPPLY CHAIN MARKET: BY END USER 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End User
• 8.2. Pharmaceutical Companies & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. CDMOs & CROs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL BIOTECH SUPPLY CHAIN MARKET: BY REGION 2022-2034 (USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Offering
  • 9.2.2 By Product Type
  • 9.2.3 By Supply Chain Stage
  • 9.2.4 By Application
  • 9.2.5 By End User
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Offering
  • 9.3.2 By Product Type
  • 9.3.3 By Supply Chain Stage
  • 9.3.4 By Application
  • 9.3.5 By End User
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Offering
  • 9.4.2 By Product Type
  • 9.4.3 By Supply Chain Stage
  • 9.4.4 By Application
  • 9.4.5 By End User
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Offering
  • 9.5.2 By Product Type
  • 9.5.3 By Supply Chain Stage
  • 9.5.4 By Application
  • 9.5.5 By End User
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Offering
  • 9.6.2 By Product Type
  • 9.6.3 By Supply Chain Stage
  • 9.6.4 By Application
  • 9.6.5 By End User
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL BIOTECH SUPPLY CHAIN INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Deutsche Post AG
  • 11.2.2 United Parcel Service Of America Inc
  • 11.2.3 Cencora Inc
  • 11.2.4 FedEx Healthcare Solutions
  • 11.2.5 Kuehne+Nagel
  • 11.2.6 McKesson Corporation
  • 11.2.7 Cardinal Health
  • 11.2.8 Thermo Fisher Scientific Inc
  • 11.2.9 Catalent Inc
  • 11.2.10 A.P. Moller - Maersk
  • 11.2.11 DB Schenker
  • 11.2.12 CEVA Logistics
  • 11.2.13 DSV A/S
  • 11.2.14 GXO Logistics
  • 11.2.15 SF Express
  • 11.2.16 Cryoport Inc
  • 11.2.17 Marken
  • 11.2.18 World Courier
  • 11.2.19 DHL Global Forwarding
  • 11.2.20 Lineage Logistics